首页 正文

Dose optimization of sacubitril/valsartan in Chinese chronic heart failure patients: integration of physiologically based pharmacokinetic modeling and real-world data

{{output}}
Objective: In routine clinical practice, many patients with chronic heart failure (CHF) treated with sacubitril/valsartan do not achieve the guideline-recommended target dose of 200 mg twice daily (BID), largely because of tolera... ...